Temporary suspension of sorafenib by adverse effects is associated with longer survival in patients with hepatocellular carcinoma
Rodríguez-Escaja, C., de Jorge Turrión, M.A., García, A.C., Díaz, E.R., González-Diéguez, M.L., Álvarez-Navascués, C., Cadahía-Rodrigo, V., Rodríguez, M., Varela, M.Volume:
66
Year:
2017
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/S0168-8278(17)31272-2
File:
PDF, 100 KB
english, 2017